Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profe...
| RVP | Peers | Sector | |
|---|---|---|---|
Market Cap | 22.573 M | 259.8 M | 65.396 M |
Price % of 52 Week High | - | 68.9% | 62.3% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | - | -1.7% | -0.7% |
1 Year Price Total Return | -36.6% | -9.0% | -11.0% |
Beta (5 Year) | 2.09 | 1.54 | 0.64 |
No data available
| (presentment in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Sep-24 | Sep-23 | Sep-24 |
| Income Statement | |||||
| Revenue | 95 | 44 | 38 | 10 | 10 |
| Operating Income | (0.85) | (11) | (17) | (0.94) | (5.14) |
| Net Profit | 5.08 | (7.01) | (16) | (4.06) | (1.92) |
| Diluted EPS | 0.15 | -0.24 | -0.53 | -0.14 | -0.070 |
| EBITDA | 3.75 | (3.96) | (9.28) | 1.01 | (3.23) |
| Balance Sheet | |||||
| Cash & ST Invest. | 49 | 47 | 37 | 45 | 37 |
| Current Assets | 89 | 78 | 69 | 78 | 69 |
| Total Assets | 196 | 180 | 158 | 182 | 158 |
| Current Liabilities | 12 | 9.38 | 8.02 | 9.26 | 8.02 |
| Total Liabilities | 89 | 80 | 74 | 82 | 74 |
| Total Equity | 107 | 99 | 83 | 99 | 83 |
| Total Debt | 1.82 | 1.54 | 1.31 | 1.61 | 1.31 |
| Cash Flow Statement | |||||
| Cash Flow Operations | 17 | 2.77 | (8.56) | 7.80 | (5.73) |
| Cash From Investing | (31) | (11) | 1.75 | (0.56) | 2.93 |
| Cash From Financing | 4.99 | 0.94 | (0.53) | (0.13) | (0.13) |
| Free Cash Flow | (0.06) | 1.91 | (9.85) | 7.66 | (6.52) |